Occurrence of graft-versus-host disease increases mortality after umbilical cord blood transplantation for acute myeloid leukaemia: a report from Eurocord and the ALWP of the EBMT.
Fréderic BaronAnnalisa RuggeriE BeohouM LabopinM MohtyJ SanzS VigourouxS FurstA BosiP ChevallierJ J CornelissenM MichalletJ SierraD KarakasisB N SavaniE GluckmanA NaglerPublished in: Journal of internal medicine (2017)
The occurrence of grade II-IV acute or chronic GVHD each increases overall mortality after UCBT for AML mitigating the possible graft-versus-leukemia effect of GVHD.
Keyphrases
- umbilical cord
- acute myeloid leukemia
- liver failure
- allogeneic hematopoietic stem cell transplantation
- mesenchymal stem cells
- respiratory failure
- drug induced
- risk assessment
- bone marrow
- aortic dissection
- hepatitis b virus
- stem cells
- intensive care unit
- cell therapy
- immune response
- extracorporeal membrane oxygenation
- mechanical ventilation